Navigation Links
Astrocyte signaling sheds light on stroke research
Date:3/18/2013

p food, were tested. In addition, tissue samples were taken from both groups and compared.

"Mice with altered astrocyte signaling had limited damage after the stroke" said first author Dustin Hines, Ph.D., a post-doctoral fellow in the department of neuroscience at Tufts University School of Medicine. "Manipulating the astrocyte signaling demonstrates that astrocytes are critical to understanding the spread of damage following stroke."

"Looking into ways to utilize and enhance the astrocyte's protective properties in order to limit damage is a promising avenue in stroke research," said senior author Phillip Haydon, Ph.D. Haydon is the Annetta and Gustav Grisard professor and chair of the department of neuroscience at Tufts University School of Medicine and a member of the neuroscience program faculty at the Sackler School of Graduate Biomedical Sciences at Tufts.


'/>"/>

Contact: Siobhan E. Gallagher
siobhan.gallagher@tufts.edu
617-636-6586
Tufts University, Health Sciences Campus
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Kentucky team inhibits Alzheimers biomarkers in animal model by targeting astrocytes
2. Astrocytes identified as target for new depression therapy
3. Inhibiting Hedgehog signaling pathway may improve pancreatic cancer treatment
4. Grb2 holds powerful molecular signaling pathway in check
5. Aurka-to-p53 signaling: A link between stem cell regulation and cancer
6. Scientist receives $2.8 Million to study cell signaling mechanism and develop potential therapeutics
7. Investigational agent targets gene signaling pathways to improve response for patients with CLL
8. Signaling molecule may help stem cells focus on making bone despite age, disease
9. Study sheds new light on role of genetic mutations in colon cancer development
10. Bonobo Genome Sheds Light on Their Links to Chimps, Humans
11. Genetic Research Sheds Light on Jewish Diaspora
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2013)... 2013 Dr. Ramtin Kassir is ... Jersey and NYC and a top cosmetic ... his philosophy is to provide individualized care for a broad ... laser-lifts. The surgeon is partnering with the new and emerging ... Co for its specialized needs. , "We are partnering with ...
(Date:6/20/2013)... Footwear etc. is pleased to announce the relaunch of ... new styles and colors for the spring. This line includes ... in the U.S. The relaunch is expected to be incredibly ... MBT shoes feature a unique rocker sole bottom that emulates ... outstanding shock absorption, and helps produce improved posture. Customers have ...
(Date:6/20/2013)... (PRWEB) June 20, 2013 David Icke, the ... global TV and Radio station. , Fresh from the ... David Icke is getting ready to launch ‘The Peoples Voice’ ... This station is a fantastic opportunity for journalists to cover ... from all areas of the globe. , Because this ...
(Date:6/20/2013)... City, UT (PRWEB) June 20, 2013 ... assurance solution that guides users through a HIPAA Security ... The new website launched today extends the reach of ... of HIPAA Security Officers, HIPAA Privacy Officers, security professionals, ... security, privacy, consulting, measures, processes, policies and procedures. ...
(Date:6/19/2013)... Everyone is looking for ways to improve general health. Sublime ... It is called Skin Brushing . Skin Brushing can be ... - to improve health and skin quality. It is fun ... Skin Brushing improves general health because:, , it ... to drain toxins , it clears skins of dead ...
Breaking Medicine News(10 mins):Health News:Celebrity Plastic Surgeon Dr. Kassir Teams Up With X Factor Selling Systems to Enhance Patient Experience 2Health News:Footwear etc. Announces New MBT Shoes for Spring/Summer 2Health News:Modern Compliance Solutions Launches a New Web Site Promoting the Industry-Proven, Web-Based HIPAA One Security Solution 2Health News:A Fast and Fun Way to Better Skin Quality and Overall Health, says Sublime Beauty® 2
... ... approval of its biologics license application (BLA) for the first 15 monoclonal antibodies in its ... an exclusive agreement with the MED Alliance Group, Inc. (MAGI) to serve as its distributor ... ...
... DALLAS, Oct. 28 Parkland Health & Hospital ... limited English speaking patients by expanding its language ... Phones in patient rooms and other locations throughout ... from Language Line Services, the leading interpretation and ...
... Inc., a subsidiary of Eisai Inc., announced today that ... Ortho Biotech Inc. for development and commercialization of an ... solid tumors. , Under the terms of ... license for the development, manufacture and sale of the ...
... 28 /PRNewswire-Asia/ -- Winner Medical Group Inc.,(AMEX: WWIN ... and,the largest exporter by volume in the medical dressing ... (Shenzhen) Co., Ltd., or,"Winner Shenzhen", won a Contribution in ... The winner of the Contribution in ...
... Connectyx Technologies Holdings Group Inc. (Pink Sheets: CTYX), announced ... revolutionary tool for the management of medical, health and lifestyle ... internet based, data storage and transfer platform that allows a ... features secure storage and access to data from a variety ...
... LONDON, October 28 Parents looking to ... advised to buy,BornFree(TM), the world,s leading brand for baby ... (BPA), which is now available,across the UK. , ... BPA leach into food or beverages,stored in polycarbonate containers, ...
Cached Medicine News:Health News:Quotient Biodiagnostics Signs MED Alliance Group, Inc. as Exclusive Distributor in Midwest for Line of Transfusion Diagnostics 2Health News:Quotient Biodiagnostics Signs MED Alliance Group, Inc. as Exclusive Distributor in Midwest for Line of Transfusion Diagnostics 3Health News:Parkland Health & Hospital System Expands Language Access with Language Line(R) Phones in Every Patient Room 2Health News:Parkland Health & Hospital System Expands Language Access with Language Line(R) Phones in Every Patient Room 3Health News:Morphotek(R), Inc. Announces a Licensing Deal With Centocor Ortho Biotech Inc. for Exclusive Development and Commercialization Rights for a Therapeutic Monoclonal Antibody 2Health News:Winner Medical's Subsidiary Won Contribution in Chinese Nonwovens and Industrial Textiles Industry Award 2Health News:Winner Medical's Subsidiary Won Contribution in Chinese Nonwovens and Industrial Textiles Industry Award 3Health News:Connectyx Announces the MedFlash Personal Health Manager 2Health News:Connectyx Announces the MedFlash Personal Health Manager 3Health News:BornFree Baby Bottles Borne Into Britain 2
(Date:6/19/2013)... 2013  Decision Resources, one of the world,s ... healthcare issues, finds that, for the treatment of ... European rheumatologists cite a therapy,s induction of remission ... their prescribing decisions. Over 60 percent and 70 ... the percentage of patients achieving remission at six ...
(Date:6/19/2013)... , June 19, 2013 BD Biosciences, a segment ... ), a leading global medical technology company, today announced the ... the latest in its line of high-performance research flow cytometers. ... high-performance multicolor analysis with the most compact footprint in its ... and a height of 30" (76.2 cm). Recognizing that space ...
(Date:6/19/2013)... , June 19, 2013 /PRNewswire-iReach/ -- ... a new specialty pharmaceutical company dedicated to ... innovative injectable and sustained release drug therapies ... medical needs, today announced the acquisition of ... Technology®) platform and associated product pipeline. Acquisition ...
Breaking Medicine Technology:U.S. and European Rheumatologists Agree That a Therapy's Induction of Remission is One of the Attributes That Most Influences Their Prescribing Decisions in Rheumatoid Arthritis 2New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 3Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 4
... Unprecedented amount of research reflects depth and breadth of, collaboration with investigators ... ... highlight impact of Zometa(R), the leading IV, bisphosphonate, on relapse rate of patients ... oral once-daily continuous, inhibitor of mTOR, including first results of RECORD-1 study in ...
... identify the, lipid core (fatty) coronary plaques of interest ... ... 15 InfraReDx, Inc. today,announced that physicians at Beaumont Hospital ... System in a patient,undergoing a cardiac catheterization. This is the ...
Cached Medicine Technology:Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 2Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 3Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 4Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 5Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 6Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 7Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 8Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 9Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 10First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 2First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 3First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 4
... Sports Medicine™ POLYSORB™ Soft Tissue Anchor 3 mm ... soft tissue to bone using sutures. The resorbable ... in the bone, and is used to attach ... a resorbable copolymer, derived from glycolide and lactide ...
... USS Sports Medicine™ POLYSORB™ Soft Tissue Anchor 2 ... attach soft tissue to bone using sutures. The ... hole in the bone, and is used to ... made of a resorbable copolymer, derived from glycolide ...
Sutureless Harpoon Tip...
... type of anchor is generally utilized when a ... into the bone. Unlike other anchors that require ... does not have that limitation. The only instrument ... a mallet. The 4.4mm Stainless Steel Anchor is ...
Medicine Products: